We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Mexican OTC Drugmaker Warned for GMP Documentation Laxity
Mexican OTC Drugmaker Warned for GMP Documentation Laxity
August 6, 2012
Compania Internacional de Comercio (CIC), a Mexican maker of OTC topical ointments and gels, has been handed an FDA warning letter for straying from the agency’s GMP regulations, including failing to document analytical tests and GMP procedures.